Project Details
Description
An open-label multicenter randomized Phase 3 study comparing then combination of DOXIL/CAELYX and YONDELIS with DOXIL/CAELYX alone in subjects with advanced relapsed ovarian cancer - Protocol ET743-OVA-301
| Status | Finished |
|---|---|
| Effective start/end date | 3/3/06 → 7/31/11 |
Funding
- JOHNSON AND JOHNSON MED INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.